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Abstract The response of bone cells to mechanical
loading is mediated by the cytoskeleton. Since the bone
anabolic agent fluoride disrupts the cytoskeleton, we
investigated whether fluoride affects the response of bone
cells to mechanical loading, and whether this is cytoskel-
eton mediated. The mechano-response of osteoblasts was
assessed in vitro by measuring pulsating fluid flow-induced
nitric oxide (NO) production. Osteocyte shape was deter-
mined in hamster mandibles in vivo as parameter of
osteocyte mechanosensitivity. Pulsating fluid flow
(0.7 ± 0.3 Pa, 5 Hz) stimulated NO production by 8-fold
within 5 min. NaF (10–50 lM) inhibited pulsating fluid
flow-stimulated NO production after 10 min, and
decreased F-actin content by *3-fold. Fluid flow-induced
NO response was also inhibited after F-actin disruption by
cytochalasin B. NaF treatment resulted in more elongated,
smaller osteocytes in interdental bone in vivo. Our results
suggest that fluoride inhibits the mechano-response of bone
cells, which might occur via cytoskeletal changes. Since
decreased mechanosensitivity reduces bone mass, the
reported anabolic effect of fluoride on bone mass in vivo is
likely mediated by other factors than changed bone cell
mechanosensitivity.
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Introduction
Bone is a living tissue capable of adapting its mass and
structure to the demands of mechanical usage [1].
Mechanical adaptation is orchestrated by the osteocytes
[2]. When bones are loaded, the resulting deformation of
the bone matrix will drive the thin layer of interstitial fluid
surrounding the network of osteocytes to flow from regions
under high pressure to regions under low pressure [3, 4].
This fluid flow is sensed by the osteocytes, which subse-
quently produce signaling molecules, e.g. nitric oxide (NO)
[5–7] which affect osteoblasts and osteoclasts to change
their bone remodeling activities leading to changes in bone
mass [8–10]. The response of bone cells to mechanical
loading is mediated by the cytoskeleton [11]. Moreover,
cell shape affects the NO response to mechanical loading,
i.e. osteocytes with a round morphology require lower
force stimulation in order to increase NO production than
osteocytes with a flat morphology [12]. Thus, any factor
changing bone cell cytoskeleton or shape may affect bone
mass.
Fluoride has been used for decades to enhance bone
mass in osteoporosis [13]. Fluoride treatment enhances
bone mass by stimulation of bone matrix deposition. Serum
concentrations of fluoride in osteoporotic patients treated
with fluoride are only 5–15 lM [14]. Fluoride at these
concentrations stimulates osteoblast proliferation, differ-
entiation, and matrix production [15–18]. Higher fluoride
concentrations increase fracture risk and peripheral bone
loss in humans, and therefore fluoride has not become
routine therapy for osteoporosis [19]. Fluoride is present in
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varying amounts in air, water, and food, and is an essential
trace element in the skeletal system and teeth [20]. Fluoride
disrupts the cytoskeleton of protozoa [21] and F-actin in
ameloblasts [22]. Since fluoride affects bone mass and
cytoskeleton, we hypothesized that fluoride inhibits the
response of mechano-sensitive bone cells to mechanical
loading.
The aim of our study was to determine whether fluoride
affects the mechano-response of bone cells in vitro, and
whether this effect is modulated via the actin cytoskeleton.
Mechano-sensitive MC3T3-E1 osteoblastic cells were
treated with or without sodium fluoride (NaF) for 24 h.
Subsequently cells were subjected to pulsating fluid flow
for 30 min. We used NO production as a parameter for
bone cell activation. We also quantified cellular F-actin
after fluoride treatment. In addition we determined the
effect of fluoride on osteocyte shape in developing hamster
mandibles in vivo. Osteocyte shape was determined as
parameter for osteocyte mechanosensitivity.
Materials and methods
MC3T3-E1 osteoblast culture
MC3T3-E1 osteoblast-like cells were cultured in
a-MEM medium (Gibco, Paisly, UK) supplemented with
100 U/ml penicillin (Sigma-Aldrich, St. Louis, MO,
USA), 50 lg/ml streptomycin (Sigma-Aldrich), 1.4 mM
L-glutamine (Sigma), 9 mM b-glycerophosphate (Sigma-
Aldrich), 1.9 mM ascorbic acid (vitamin C; Merck,
Darmstadt, Germany), and 10% fetal bovine serum
(FBS; Gibco) at 37C, in a humidified atmosphere of
5% CO2 in air. Medium was changed every 3–4 days.
Upon confluence, cells were harvested using 0.25%
trypsin and 0.1% EDTA in phosphate buffered saline
(PBS), seeded at 2 9 105 cells per 75 cm2 culture flask
(Greiner Bio-One, Kremsmuenster, Austria), and cul-
tured until the cell layer reached confluency again. Then
cells were used for pulsating fluid flow experiments as
described below.
Disruption of the actin cytoskeleton
Prior to fluid flow stimulation, plated cells were incubated
for 1 h in 13 ml of the appropriate medium with the total
serum content reduced to 2%. Cells were then divided at
random into two groups: (1) untreated control medium; (2)
actin-disrupted: medium supplemented with 1 lM cyto-
chalasin B (Sigma-Aldrich), a toxin that prevents actin
polymerization [11]. We observed that this concentration
of cytoskeletal-disrupting agent had a significant non-toxic
effect on cell morphology within 1 h.
Pulsatile fluid flow
Two days before pulsatile fluid flow (PFF) treatment, cells
were harvested from the culture flasks and seeded onto
polylysine-coated (50 lg/ml; poly-L-lysine hydrobromide,
mol wt 15–30 9 104; Sigma) glass slides (size
2.5 9 6.5 cm) at 2 9 105 cells/glass slide, and cultured
overnight in Petri dishes with 13 ml culture medium con-
taining 10% fetal bovine serum (FBS). Then the culture
medium was replaced by a-MEM medium containing 0.2%
bovine serum albumin (BSA), antibiotics, ascorbate
(Merck), and either or not 10, 25, or 50 lM NaF. Cells
were incubated for 24 h, as well as during 30 min of PFF
treatment or static control conditions.
PFF was applied as described earlier [5]. Briefly, PFF
was generated by pumping 13 ml of culture medium
through a parallel-plate flow chamber containing MC3T3-
E1 osteoblast-like cells [23]. Cells were subjected to a 5 Hz
pulse with a mean shear stress of 0.7 Pa, pulse amplitude of
0.3 Pa and a peak shear stress rate of 8.4 Pa/s [12]. Sta-
tionary control cultures were kept in a Petri dish under
similar conditions, i.e. at 37C in a humidified atmosphere
of 5% CO2 in air. After 5, 10, 15, and 30 min of PFF or
static control culture, medium was collected and assayed
for NO concentrations.
Nitric oxide
NO was measured as nitrite (NO2
-) accumulation in condi-
tioned medium using Griess reagent containing 1% sulfa-
nylamide, 0.1% naphthylethylene-diamine-dihydrochloride,
and 2.5 M H3PO4. Serial dilutions of NaNO2 in non-condi-
tioned medium were used as a standard curve. Absorbance
was measured at 540 nm with a microplate reader (BioRad
Laboratories Inc.).
DNA content
DNA was isolated directly after PFF from bone cell cul-
tures using TRIzol reagent (Gibco) according to the man-
ufacturer’s instructions. DNA in the cell lysate was
determined by CyQUANT Cell Proliferation assay
(Molecular Probes Inc., Eugene, OR, USA).
Staining of filamentous actin (F-actin)
MC3T3-E1 osteoblasts were seeded in 24 well plates at
8.0 9 103 cells/cm2 (CELLSTAR, Greiner Bio-one,
Alphen a/d Rijn, The Netherlands), incubated overnight,
followed by an additional 24 h in a-MEM with 0.2% BSA
and with or without 10, 25, or 50 lM NaF. Osteoblasts
were washed with PBS, fixed with 4.0% formaldehyde,
washed again with PBS, and incubated with 1:250 dilution
Odontology (2011) 99:112–118 113
123
of Alexa Fluor 488-phalloidin (Invitrogen) for 1 h in PBS.
F-actin was extracted using methanol and quantified as
described [24].
Tissue harvesting
A mandibular model of 4-day-old hamsters was used. In
short, a single injection of 20 mg NaF/kg body weight was
used to test whether NaF affects osteocyte size (5 ham-
sters). This concentration affects enamel development [25].
Controls (4 hamsters) received NaCl. NaF and NaCl were
administered as one single intraperitoneal injection
between 10.30 and 11.30 AM. Seventy-six hours later,
hamsters were sacrificed, mandibles excised, fixed,
demineralized, dehydrated in ascending ethyl-alcohol ser-
ies, and embedded in Historesin (Leica Microsystems,
Mannheim, Germany) [25]. Sections of 5 lm thickness
were cut with a microtome in a sagittal plane, mounted on
glass slides, and stained with hematoxylin according to
Mayer, or toluidine blue. Ethical permission was obtained
from the VU University Amsterdam.
Histology
Histologic and histomorphometric analysis was per-
formed using a Leica light microscope with electronic
stage table (Leica Microsystems, Wetzlar, Germany).
Images were captured using a Leica digital camera
directly connected to a computer. All measurements were
done using the Leica QWin Pro V 3.5.0 quantitative
imaging computer program (Leica Microsystems,
Heerbrugg, Switzerland). Within each section, three areas
of interest were distinguished: (1) mesial of the first
molar, (2) proximal of the first and second molar, and (3)
distal of the second molar. In every section these areas of
interest were located at 1009 magnification, and photo-
graphed at 4009 magnification. Osteocyte morphology
was determined by measuring length and width. Osteocyte
shape is expressed as length-over-width ratio in [500
osteocytes per hamster, and the mean shape calculated per
animal.
Statistical analysis
PFF data were obtained from 4 experiments. NO produc-
tion data are expressed as PFF-over-static control. All data
are expressed as mean ± SEM. Data were analyzed using
Wilcoxon signed-rank test for paired observations. The
unpaired t test was used for analyzing data from individual
hamsters. The paired t test was used to analyze measure-
ments between subjects in both control and experimental
animals. Differences were considered significant if
p \ 0.05.
Results
Application of fluid shear stress for 30 min to MC3T3-E1
osteoblasts in the presence or absence of NaF did not result
in visible changes in bone cell shape or alignment of cells
in the flow direction (data not shown). NaF treatment did
not affect the total amount of DNA (control, 1.6 9 10-7 g;
NaF, 1.6 9 10-7 g). No cells were removed by PFF as
assessed by microscopic inspection of the cell cultures.
We investigated whether fluoride affects the mechano-
response of MC3T3-E1 osteoblasts. Cells were cultured for
24 h in the presence or absence of NaF, and then treated
with or without PFF for 30 min. PFF caused a rapid and
significant increase in NO production at 5 min (Fig. 1a).
Twenty-four-hour incubation with 10 lM NaF signifi-
cantly inhibited PFF-induced NO production by 8-fold
(Fig. 1a). After 10 min PFF, NaF (10, 25, 50 lM) signifi-
cantly inhibited the PFF-stimulated NO response (Fig. 1b).
We also investigated the effect of PFF and cytoskeletal
disruption by cytochalasin B on the NO response of
MC3T3-E1 osteoblasts, and found that the PFF-induced
increase in NO release at 10 min was inhibited by dis-
rupting F-actin (Fig. 1c).
We then questioned whether the decrease in PFF-stim-
ulated NO production by NaF for 24 h in osteoblasts is
mediated via the actin cytoskeleton. In untreated cells,
actin fibers were aligned throughout the whole cell
(Fig. 2a). After 24 h NaF (10, 25, 50 lM) treatment, actin
fibers were at the edge of the cells and less abundant
(Fig. 2b). NaF (10, 25, 50 lM) also reduced the amount of
F-actin per well by 3-fold (Fig. 2c).
We finally tested whether fluoride affects the mechano-
sensitivity of bone cells in vivo, and therefore osteocyte
shape was determined in developing hamster mandibles.
Three areas of interest were defined, i.e. distal, mesial, and
proximal area (Fig. 3a), and the osteocyte length and width
were measured (Fig. 3b).
In the distal, mesial, and proximal area, NaF did not
affect osteocyte length (Fig. 4a). In the proximal area, but
not in the other areas, osteocyte width was 9% smaller
when treated with NaF compared to control (marginally
significant, p = 0.07) (Fig. 4b). NaF increased the osteo-
cyte length/width ratio by 3% in the mesial area (margin-
ally significant, p = 0.08), but not in the other areas
(Fig. 4c).
Discussion
Mechano-sensitive bone cells play a key role in bone
remodeling. The cytoskeleton mediates the response of
bone cells to mechanical loading, and cytoskeletal changes
can therefore affect bone remodeling [11]. Since the bone
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anabolic agent fluoride affects the cytoskeleton, we
hypothesized that (1) fluoride reduces the mechano-
response of osteoblasts to mechanical loading by pulsating
fluid flow in vitro, and that this is modulated via the actin
cytoskeleton, and (2) that fluoride affects osteocyte me-
chanosensitivity, the bone mechanosensors par excellence,
in hamster mandibles in vivo. In this report, we present
compelling evidence that treatment with fluoride at phys-
iological concentrations in vitro inhibits PFF-stimulated
NO production by MC3T3-E1 osteoblasts. The same
micromolar concentrations of fluoride affected the
arrangement and amount of F-actin in these cells. Inhibi-
tion of the NO response to PFF was also observed after
cytoskeletal disruption by cytochalasin B. The NO
Fig. 1 Effect of 24 h NaF
treatment (10, 25 or 50 lM) or
actin cytoskeleton disruption on
PFF-stimulated NO production
by MC3T3-E1 osteoblasts. NaF
inhibited the PFF-stimulated
NO production by MC3T3-E1
osteoblasts, a after 5 min PFF,
and b after 10 min PFF.
c F-actin cytoskeleton
disruption inhibited
PFF-stimulated NO production
at 10 min [11]. Values are
mean ± SEM of PFF-treated-
over-static control ratios (T/C of
5 independent experiments).
Dashed line, T/C = 1 (no
effect). Stat stationary control
culture, PFF pulsating fluid
flow. *Significantly different
from 1; #Significantly different
from untreated, p \ 0.05
Fig. 2 Immunofluorescence
analysis and quantification of
actin cytoskeleton in MC3T3-
E1 osteoblasts. F-actin (green)
was visualized with alexa fluor
488 phalloidin. Representative
images of a control MC3T3-E1
osteoblasts, and b F-actin
cytoskeleton in MC3T3-E1
osteoblasts after 24 h NaF
(10 lM) treatment.
c Quantification of F-actin in
MC3T3-E1 osteoblasts. Values
are mean ± SEM of 4 cultures
from 2 independent
experiments. *Significant effect
of NaF on F-actin, p \ 0.05
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production (PFF/Stat) in the control (0 lM) is about 8 in
Fig. 1a, b, while in Fig. 1c, NO production (PFF/Stat) in
‘‘untreated’’ is about 1.8. We adopted Fig. 1c from
McGarry et al. [11]. In these experiments, a low percentage
of serum (2%) was present in the culture medium during
the mechanical loading (PFF) experiments. In our experi-
ments (Fig. 1a, b) 0.3% BSA was added to the medium
rather than serum. Serum in culture medium will not alter
the activation of biological pathways by PFF in osteoblasts,
but serum does alter the magnitude of the response of
osteoblasts to pulsating fluid flow (unpublished observa-
tions within our laboratory). In addition, we found that
fluoride marginally changes osteocyte shape in the mesial
region in hamster mandibles in vivo. Fluoride treatment
resulted in more elongated and smaller osteocytes. Why
this occurs only in the mesial region is not clear. Our
results suggest that fluoride inhibits the mechano-response
of bone cells by cytoskeletal changes.
We applied mechanical loading by PFF of 0.7 ± 0.3 Pa
at 5 Hz. This stimulus is based on the currently available
knowledge on physiological bone loading stimuli. The
frequency spectra after loading of the hip bone in living
humans have been calculated to range between 1 and 3 Hz
for walking cycles and reaching 8–9 Hz for running cycles
[26]. The fluid shear stress amplitude around osteocytes,
resulting from daily mechanical loads, have been deter-
mined theoretically to range from 0.8 to 3 Pa due to
physiological strains in humans [23]. Although the accu-
racy of these calculations is currently under debate, it is
noteworthy that bone cells in vitro seem to be highly
sensitive to shear stress in the order of this magnitude.
We showed that fluoride affects the arrangement and
amount of F-actin in MC3T3-E1 osteoblasts. These find-
ings agree with a study showing that fluoride affects the
activity of several g-proteins involved in the microtubular
system and other cytoskeletal compounds in protozoa [21].
Since the response of bone cells to mechanical loading is
mediated by the cytoskeleton [11], our findings suggest that
fluoride affects the mechano-response of osteoblasts via
modulation of cellular F-actin.
Another explanation for the fluoride-induced decrease in
NO response to mechanical loading by PFF in MC3T3-E1
osteoblasts could be increased activity of superoxide dis-
mutase (SOD). Fluoride induces oxidative damage in
mouse osteoblasts [27]. Oxidative damage in cells by
reactive oxygen species is controlled by increasing SOD
activity. SOD scavenges free radicals such as NO, and
turns these into oxygen and hydrogen peroxide [28]. It is
possible that in the presence of NaF, osteoblasts experi-
enced oxidative stress and did respond with increased SOD
activity, thereby eliminating the NO produced as a result of
PFF treatment.
The effect of fluoride on the arrangement and amount of
F-actin in osteoblasts in vitro is in agreement with our in
vivo observations. Fluoride did not affect osteocyte length
in the mesial, distal, and proximal regions of the hamster
mandible, but it decreased osteocyte width in the proximal
region and increased osteocyte length-over-width ratio in
the mesial region, indicating that a single high dose of NaF
in hamster pups resulted in the formation of more elon-
gated and smaller osteocytes in the growing mandible.
Bone around developing molar teeth has a high turnover,
and osteoblasts briefly exposed to fluoride turn into
osteocytes within 3 days. Our results suggest that fluoride
inhibits the mechano-response via cytoskeletal changes
resulting in changes in osteocyte morphology, since dif-
ferences in osteocyte morphology indicate differences in
mechanosensitivity [12].
The decreased NO response to mechanical loading by
PFF, in combination with the affected cytoskeleton and the
smaller osteocytes in vivo, as a result of fluoride treatment
suggest that bone cell mechanosensitivity is affected by
fluoride. We conclude that fluoride causes rearrangement
Fig. 3 Histological section of a hamster first and second molar
showing the areas of interest for determining osteocyte morphology.
a Undecalcified, hematoxylin–eosin stained section of a first (M1) and
second (M2) hamster molar at post-natal day 4 from an animal
injected with 20 mg NaF/kg body weight, and killed 76 h later,
showing the three areas of interest, i.e. proximal area (p), mesial area
(m), and distal area (d) (magnification, 950). b Higher magnification
of a stained with toluidine blue (magnification, 9400). The square
shows a single osteocyte, and lines with double arrow heads indicate
length and width of the osteocyte. Ocl osteoclast, Ob osteoblast, OCt
osteocyte, B bone
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of the actin cytoskeleton, thereby changing osteocyte shape
and mechanical loading-induced NO production. The
known anabolic effect of fluoride on bone mass is therefore
likely mediated by other factors than changed bone cell
mechanosensitivity.
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